Jame Abraham: Thank you, Monica Bertagnolli, for your service
Jame Abraham, Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic, shared a post on X:
“Thank you, Monica Bertagnolli, for your service! Huge loss for cancer research community! Statement from Monica M. Bertagnolli, M.D., on ending her tenure as NIH director.”
Read the post “Monica Bertagnolli is ending her tenure as NIH director” on oncodaily.com.
Jame Abraham, MD, FACP, is Chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic and a Professor of Medicine at Cleveland Clinic Lerner College of Medicine. He also is a Deputy Editor at the ASCO Post and Journal of Oncology Practice of ASCO.
Dr. Abraham is a member of the National Comprehensive Cancer Network (NCCN) Breast Cancer Committee and holds leadership roles in NRG Oncology and the National Surgical Adjuvant Breast and Bowel Project (NSABP).
Monica Bertagnolli is the former Director of the National Institutes of Health (NIH), USA. She is the President of Alliance for Clinical Trials In Oncology Foundation.
She previously served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute.
Dr. Bertagnolli is the Founding Chair of the minimal Common Oncology Data Elements (mCODE) executive committee and has held multiple positions nationally, including being Past President and Chair of the Board of Directors of the American Society of Clinical Oncology.
In 2021, she was elected to the National Academy of Medicine, having previously served on the National Academies National Cancer Policy Forum.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023